NKTX Cash-Secured Put Strategy
NKTX (Nkarta, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
NKTX (Nkarta, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $218.1M, a beta of 0.89 versus the broader market, a 52-week range of 1.63-3.65, average daily share volume of 822K, a public-listing history dating back to 2020, approximately 157 full-time employees. These structural characteristics shape how NKTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.89 places NKTX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a cash-secured put on NKTX?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
Current NKTX snapshot
As of May 15, 2026, spot at $2.67, ATM IV 111.60%, IV rank 37.71%, expected move 31.99%. The cash-secured put on NKTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this cash-secured put structure on NKTX specifically: NKTX IV at 111.60% is mid-range versus its 1-year history, so the credit collected on a NKTX cash-secured put sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 31.99% (roughly $0.85 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NKTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on NKTX should anchor to the underlying notional of $2.67 per share and to the trader's directional view on NKTX stock.
NKTX cash-secured put setup
The NKTX cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NKTX near $2.67, the first option leg uses a $2.54 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NKTX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NKTX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $2.54 | N/A |
NKTX cash-secured put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
NKTX cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on NKTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use cash-secured put on NKTX
Cash-secured puts on NKTX earn premium while a trader waits to acquire NKTX stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning NKTX.
NKTX thesis for this cash-secured put
The market-implied 1-standard-deviation range for NKTX extends from approximately $1.82 on the downside to $3.52 on the upside. A NKTX cash-secured put lets a trader earn premium while waiting to acquire NKTX at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current NKTX IV rank near 37.71% is mid-range against its 1-year distribution, so the IV signal is neutral; the cash-secured put thesis on NKTX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, NKTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NKTX-specific events.
NKTX cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NKTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NKTX alongside the broader basket even when NKTX-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on NKTX carry tail risk when realized volatility exceeds the implied move; review historical NKTX earnings reactions and macro stress periods before sizing. Always rebuild the position from current NKTX chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on NKTX?
- A cash-secured put on NKTX is the cash-secured put strategy applied to NKTX (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With NKTX stock trading near $2.67, the strikes shown on this page are snapped to the nearest listed NKTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are NKTX cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the NKTX cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 111.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a NKTX cash-secured put?
- The breakeven for the NKTX cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current NKTX market-implied 1-standard-deviation expected move is approximately 31.99%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on NKTX?
- Cash-secured puts on NKTX earn premium while a trader waits to acquire NKTX stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning NKTX.
- How does current NKTX implied volatility affect this cash-secured put?
- NKTX ATM IV is at 111.60% with IV rank near 37.71%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.